Human CYFRA21-1(Cytokeratin Fragment Antigen 21-1) CLIA Kit

The Human CYFRA21-1 (Cytokeratin Fragment Antigen 21-1) CLIA Kit is a highly advanced and reliable diagnostic tool designed for the accurate detection and quantification of CYFRA21-1 in human serum or plasma samples. This kit utilizes the Chemiluminescent Immunoassay (CLIA) technique, which ensures exceptional sensitivity and specificity in detecting CYFRA21-1, a biomarker associated with various types of cancers, particularly lung cancer.

With its state-of-the-art technology, this CYFRA21-1 CLIA Kit offers unparalleled precision and reproducibility, making it an indispensable tool for clinical laboratories and healthcare professionals. The kit includes all the necessary components, including pre-coated microplates, reagents, and controls, ensuring convenience and ease of use.

The CYFRA21-1 CLIA Kit provides accurate and reliable results within a short turnaround time, enabling prompt diagnosis and monitoring of cancer progression. Its wide dynamic range allows for the detection of CYFRA21-1 in both low and high concentrations, ensuring accurate assessment across a broad spectrum of patient samples.

This CYFRA21-1 CLIA Kit complies with international quality standards and has undergone rigorous testing to ensure its performance and reliability. It is suitable for use in clinical laboratories, research institutions, and hospitals, aiding in the early detection and management of cancer.

Invest in the Human CYFRA21-1 CLIA Kit to enhance your diagnostic capabilities and contribute to improved patient outcomes.